dat.begg1989: Studies on Bone-Marrow Transplantation versus Chemotherapy...

In metadat: Meta-Analysis Datasets

Studies on Bone-Marrow Transplantation versus Chemotherapy for the Treatment of Leukemia

Description

Results from controlled and uncontrolled studies on the effectiveness of allogeneic bone-marrow transplantation (BMT) and conventional chemotherapy (CMO) in the treatment of acute nonlymphocytic leukemia.

Usage

dat.begg1989

Format

The data frame contains the following columns:

study	numeric	study number
trt	character	treatment (BMT or CMO)
arms	numeric	number of arms in the study (1 = uncontrolled studies; 2 = controlled studies)
yi	numeric	2-year disease-free survival rates
sei	numeric	corresponding standard errors
vi	numeric	corresponding sampling variances

Details

The dataset includes the results from controlled and uncontrolled studies on the 2-year disease-free survival rate in patients with acute nonlymphocytic leukemia receiving either allogeneic bone-marrow transplantation (BMT) or conventional chemotherapy (CMO). In the controlled (two-arm) studies (studies 1-4), a cohort of patients in complete remission and potentially eligible for BMT was assembled, and those who consented and for whom a donor could be found received BMT, with the remaining patients used as controls (receiving CMO). In the uncontrolled (one-arm) studies (studies 5-16), only a single group was studied, receiving either BMT or CMO.

The data in this dataset were obtained from Table 1 in Begg and Pilote (1991, p. 902).

Concepts

medicine, oncology, single-arm studies, multilevel models

Author(s)

Wolfgang Viechtbauer, [e-mail], https://www.metafor-project.org

Source

Begg, C. B., & Pilote, L. (1991). A model for incorporating historical controls into a meta-analysis. Biometrics, 47(3), 899–906. https://doi.org/10.2307/2532647

References

Begg, C. B., Pilote, L., & McGlave, P. B. (1989). Bone marrow transplantation versus chemotherapy in acute non-lymphocytic leukemia: A meta-analytic review. European Journal of Cancer and Clinical Oncology, 25(11), 1519–1523. https://doi.org/10.1016/0277-5379(89)90291-5

Examples

### copy data into 'dat' and examine data
dat <- dat.begg1989
dat

## Not run: 

### load metafor package
library(metafor)

### turn trt and arms into factors and set reference levels
dat$trt  <- relevel(factor(dat$trt), ref="CMO")
dat$arms <- relevel(factor(dat$arms), ref="2")

### create data frame with the treatment differences for the controlled studies
dat2 <- data.frame(yi = dat$yi[c(1,3,5,7)] - dat$yi[c(2,4,6,8)],
                   vi = dat$vi[c(1,3,5,7)] + dat$vi[c(2,4,6,8)])
dat2

### DerSimonian and Laird method using the treatment differences
res <- rma(yi, vi, data=dat2, method="DL", digits=2)
res

### Begg & Pilote (1991) model incorporating the uncontrolled studies
res <- rma.mv(yi, vi, mods = ~ trt, random = ~ 1 | study,
              data=dat, method="ML", digits=2)
res

### model involving bias terms for the uncontrolled studies
res <- rma.mv(yi, vi, mods = ~ trt + trt:arms, random = ~ 1 | study,
              data=dat, method="ML", digits=2)
res

### model with a random treatment effect
res <- rma.mv(yi, vi, mods = ~ trt, random = list(~ 1 | study, ~ trt | study),
              struct="UN", tau2=c(0,NA), rho=0, data=dat, method="ML", digits=2)
res

### model with a random treatment effect, but with equal variances in both arms
res <- rma.mv(yi, vi, mods = ~ trt, random = list(~ 1 | study, ~ trt | study),
              struct="CS", rho=0, data=dat, method="ML", digits=2)
res


## End(Not run)

metadat documentation built on April 6, 2022, 5:08 p.m.